Early and midgestational decidua of mice genetically ablated for expression of the natural killer (NK) cell natural cytotoxicity receptor (NCR; Ncr1
INTRODUCTION
Successful human and mouse pregnancy involves contributions from large, multilineage decidual leukocyte populations. Dominant in early decidua basalis (DB) are proliferative uterine natural killer (uNK) cells. 1, 2 Human uNK cells are globally identified by their CD56 bright CD16
À surface phenotype. 3 In mice, two major uNK cell subsets are histologically distinguished by reactivity with Dolichos biflorus agglutinin (DBA) lectin. 4 Most DBA-uNK cells (72%) co-express Ly49C/I and NK1.1. 1 Neither DBA þ nor DBAuNK cells use the transcription factor NFIL3 (E4BP4) for differentiation, a requirement for peripheral NK (pNK) cells. 5, 6 Mature uNK cells (DBA þ and DBA-) contain large numbers of cytoplasmic granules with contents that include perforin (PRF) and granzyme A (GZMA), [7] [8] [9] [10] but uNK cells have limited cytotoxicity in vitro. 10 In human uNK cells, failed microtubular assembly has been documented to prevent polarization of PRF-containing granules during immune synapse formation. 11 Mouse and human uNK cells are recognized as important producers of cytokines and angiokines within DB 3, 8, [12] [13] [14] with functional products differing between DBA þ and DBA-uNK cell subsets. 12, 13 As in pNK cells, uNK cells express numerous activating and inhibitory receptors that drive their functions. Human uNK cells constitutively express killer immunoglobulin-like receptors that interact with major histocompatibility complex (MHC) molecules expressed by invading trophoblast cells. 15 In mice, uNK cells utilize LY49 lectin receptors to recognize MHC. LY49 receptor family usage contributes to uNK cell granule biogenesis, synthesis of vascular endothelial growth factor (VEGF), early decidual angiogenesis, and midgestational, uNK cell-initiated, spiral arterial remodeling. 16 Other NK cell receptors bind non-MHC ligands. Natural cytotoxicity receptors (NCRs) are expressed by human and mouse pNK and uNK cells. In humans, pNK and uNK cells express different splice variants of NKp46/NCR1, NKp44/NCR2, and NKp30/NCR3 and the altered NKp30 and NKp44 receptor isoform profile of uNK cells is associated with decreased cytotoxicity, secretome modifications, and impaired immune synapse formation. 17 NCR1, the murine NKp46 homolog, 18 is expressed on pNK and uNK cells, 19 with dramatically higher expression by DBA þ than by DBA-uNK cells. 20 NCRs have multiple roles in non-pregnant humans and mice. In humans, NCRs are essential for in vitro lysis of cancer cell lines 21 and recognition of herpes simplex virus-infected cells. 22 In mice, NCR1 is implicated in influenza virus clearance 23 and in intestinal mucosal defense. 24 In both species, NKp46/NCR1 is implicated in development of type 1 diabetes through recognition of ligands on and subsequent killing of pancreatic b cells. 25 Human clinical investigations identified NKp46 þ uNK cell in decidual cell suspensions from mid-secretory phase endometrial biopsies of women experiencing recurrent pregnancy loss. 26 Others report NKp46 þ pNK cells are less frequent in human pregnancies complicated by gestational diabetes. 27 In vitro studies of first trimester human uNK cells also found that antibody-dependent engagement of NKp46 induced PRF polarization and degranulation; 17, 28 cytotoxicity, however, was blocked by co-engagement of the uNK cell inhibitory receptor NKG2A. 28 NKp46 cross-linking of first trimester human uNK cells also induces dose-dependent production of cytokines that include VEGF and placental growth factor (PGF). 8, 17 Only one report has addressed NCR1 contributions during mouse pregnancy using an Ncr1-deficient mouse with a green fluorescent protein (GFP) reporter cassette replacing Ncr1 (MAR-1). 18, 23 Ncr1 loss delayed conceptus growth and elevated fetal resorption frequency. 20 Histological and whole-mount in situ immunohistochemical (WM-IHC) studies of these Ncr1-deficient implantation sites also identified smaller uNK cells, impaired decidual angiogenesis, and delayed spiral arterial remodeling. 20 Here we address the roles of NCR1 in uNK subtype differentiation, cytoplasmic granule and angiokine synthesis, and DBA þ uNK cell conjugate formation in early decidua.
RESULTS

Fecundity and fertility in Ncr1
Gfp/Gfp mice
Ncr1
Gfp/Gfp Â Ncr1 Gfp/Gfp breeding pairs housed at Queen's University, produced an average of 5.1 pups per litter, with a Gfp/Gfp decidua basalis (i) and Type IV uNK cells (yellow circle) are observed for the first time. In gd12.5 MLAp (ii), only Type I-III uNK cells occur (circled). Images are representative of three separate staining series using two implantation sites from three different pregnancies. DBA, dolichos biflorus agglutinin; DB, decidua basalis; gd, gestation day; GFP, green fluorescent protein; MLAp, mesometrial lymphoid aggregate of pregnancy; NCR1, natural cytotoxicity receptor; uNK, uterine natural killer.
male:female pup ratio of 1.04:1 (n ¼ 41 live-born litters). In 14.6% of litters, pups were found dead shortly after parturition. For Ncr1
Gfp/Gfp females killed during pregnancy (n ¼ 51), the average pups per pregnancy was 8.1 equally distributed between right and left uterine horns. The rate of sterile mating (i.e., copulation plug but no pregnancy) in Ncr1
Gfp/Gfp females was 25.5%. These are in line with values previously reported 16 and observed in our facilities for B6 mice. Fetal resorptions occurred in 26.3% of Ncr1
Gfp/Gfp pregnancies (n ¼ 38) and represented 10.6% of all implant sites (n ¼ 333), rates higher than in our B6 pregnancies (resorptions in 15.0% of pregnancies (n ¼ 20); 2.4% of all implant sites (n ¼ 165)).
Delayed uNK cell maturation in Ncr1
Gfp/Gfp mice Previous studies found that Ncr1 loss did not alter uNK cell numbers or DBA þ /DBA À uNK cell proportions between gestation day (gd)6.5 and 12.5, but identified smaller uNK cells at these gd. 20 To determine if smaller Ncr1 Gfp/Gfp uNK cells reflected delayed maturation, maturation subtypes I-IV of DBA þ uNK cells residing in the decidua (Supplementary Figure S1 online) were scored using morphologically defined criteria (diameter, number of cytoplasmic granules, and nuclear morphology (Figure 1) ). 4, 6 At gd6.5, most DBA þ uNK cells in B6 and Ncr1
Gfp/Gfp mice were small, agranular Type I uNK cells ( Figure 1a) . A significantly smaller proportion of cells in both B6 and Ncr1
Gfp/Gfp mice were Type II uNK cells with slightly larger diameters and few DBA þ cytoplasmic granules. No Type III or IV cells were present in gd6.5 decidua in either strain. The proportion of Type I uNK cells was significantly higher in Ncr1
Gfp/Gfp compared with B6 mice (P ¼ 0.047) and there was a relative deficit in the proportion of Type II uNK cells in Ncr1
Gfp/Gfp compared with B6 ( Table 1 ; P ¼ 0.047). At gd8.5, Type I and Type II uNK cells were present in high numbers (Figure 1b) , heavily granulated Type III uNK cells were observed but senescent Type IV cells were absent in both genotypes. There were no significant differences between B6 and Ncr1
Gfp/Gfp mice in the proportions of Type I (P ¼ 0.379), Type II (P ¼ 0.412), or Type III (P ¼ 0.553) uNK cells at gd8.5 ( Table 1) .
By gd10.5, the MLAp is a fully differentiated region distinct from DB (Supplementary Figure S1) . The MLAp contains different proportions of uNK cell subtypes than DB (Figure 1c) . At gd10.5, gd Ncr1
Gf/p/Gfp and B6 DB mice had similar proportions of Type I uNK cells (P ¼ 0.505 but a higher frequency of Type II (P ¼ 0.033) and slightly diminished frequency of Type III uNK cells (P ¼ 0.054) persisted in Ncr1
Gfp/Gfp mice ( Table 1) . MLAp typically has a higher proportion of immature uNK cells than DB (Figure 1c) . This was observed at gd10.5 with higher proportions of Type I uNK cells in B6 and Ncr1
Gfp/Gfp MLAp ( Table 1) . In B6, similar proportions of Type II uNK cells were present in the MLAp and DB (P ¼ 0.849), but Type III cell proportions were lower in MLAp vs. DB (Po0.001). Type IV cells were absent from both regions. In gd10.5 Ncr1
Gfp/Gfp , Type II (P ¼ 0.015) and Type III (P ¼ 0.003) uNK cell subtypes were less frequent in the MLAp (Table 1; Figure 1c ). There were no significant gd10.5 differences in uNK cell subtype proportions in the MLAp ( Table 1) .
In gd12.5 DB Type I uNK cells were absent in B6 but persisted in Ncr1
Gfp/Gfp (Po0.001) ( Table 1 ). The Type II uNK cell proportion was also greater in DB of Ncr1
Gfp/Gfp than B6 (P ¼ 0.009) but Type III uNK cell frequencies were similar (P ¼ 0.285). Fully mature Type IV uNK cells, which are normally first observed at gd12.5 (Figure 1d ), tended to be less frequent in Ncr1
Gfp/Gfp DB (P ¼ 0.063) ( Table 1 ). Gd12.5 uNK cells remained more immature in the MLAp than DB for both genotypes (Figure 1d ). Type I uNK cells were absent from B6 MLAp but present in Ncr1
Gfp/Gfp MLAp. Type II uNK cells were more frequent in MLAp than DB in B6 (P ¼ 0.014) and Ncr1
Gfp/Gfp mice (P ¼ 0.053), whereas Type III uNK cell Acquisition of cytoplasmic granules that contain lytic proteins characterizes uNK cell maturation. 4, 9 Ultrastructural analyses of B6 and Ncr1
Gfp/Gfp decidua at gd6.5 revealed low numbers of uNK cells containing round, immature cytoplasmic granules. The granules were markedly smaller in Ncr1
Gfp/Gfp uNK cells ( Figure 2b ). By gd8.5, granules were more abundant but remained smaller and more immature in Ncr1
Gfp/Gfp than in B6 ( Figure 2d ). By gd10.5, B6 uNK cell granules had acquired their classical mature phenotype; i.e., round, relatively large, and showing a secretory-lysosome double-compartment morphology with a defined cortical cap and solid, uniformly electron dense core 30 ( Figure 2e ). In contrast, Ncr1 Gfp/Gfp uNK cell granules displayed abnormal shapes and many lacked the double compartment phenotype or had anomalous, variable core electron density (Figure 2f ).
To determine if impaired cytoplasmic granule development in Ncr1
Gfp/Gfp uNK cells altered PRF or GZMA expression, immunohistochemistry was undertaken to assess lytic protein expression in DBA þ uNK cells between gd6.5 and 12.5. Importantly, numbers of DBA þ granules expressed by matched uNK cell subtypes were similar between the strains at each gd (data not shown). At gd6.5 when most DBA þ uNK cells are Type I agranular cells (see above), 63.4±9.9% of B6 and 37.6 ± 6.1% of Ncr1
Gfp/Gfp DBA þ uNK cells diffusely expressed both PRF and GZMA (P ¼ 0.018). An additional 13.2 ± 7.9% of B6 and 13.9 ± 4.3% of Ncr1
Gfp/Gfp of DBA þ uNK cells expressed PRF without GZMA reactivity (P ¼ 0.893). When both dual and single expression was considered, total Ncr1
Gfp/Gfp uNK cells expressing lytic protein were diminished vs. B6 (P ¼ 0.026) ( Table 1) . Neither genotype at gd6.5 nor later studied gd had DBA þ uNK cells solely reactive for GZMA, whereas some DBA þ uNK cells were nonreactive for both PRF and GZMA at all gd ( Figure 3) .
By gd8.5, Type II and III uNK cells (evident granules) had become more abundant and cytolytic protein expression was less diffuse and more localized to DBA þ granules (Figure 3b ).
Gd8.5 Ncr1
Gfp/Gfp continued to have fewer dually expressing DBA þ uNK cells than B6 (P ¼ 0.003) but their proportion of PRF only reactivity was significantly higher (Po0.001). The total proportion of gd8.5 DBA þ uNK cells expressing lytic proteins did not differ between genotypes (P ¼ 0.551) ( Table 1) .
At gd10.5 when DB and MLAp are distinct regions ( Figure 3c ; Supplementary Figure S1 ), the proportion of DBA þ uNK cells in DB co-expressing PRF and GZMA remained lower in Ncr1
Gfp/Gfp than B6 (P ¼ 0.038) and the statistical difference in sole PRF expression was sustained (P ¼ 0.042). DBA þ uNK cells expressing both PRF and GZMA were less frequent in the MLAp than in DB of both B6 (P ¼ 0.001) and Ncr1
Gfp/Gfp-(Po0.001), whereas the proportion of DBA þ uNK cells expressing only PRF was greater in the MLAp than DB in both strains ( Table 1) . Between strains in MLAp, no significant differences were observed in proportions of dually (P ¼ 0.296) or singly (P ¼ 0.964) expressing DBA þ uNK cells ( Table 1) .
In gd12.5 DB, DBA þ uNK cell expression of both lytic proteins (P ¼ 0.076) or sole PRF expression (P ¼ 0.341) did not differ between Ncr1
Gfp/Gfp and B6 uNK cells ( Table 1 ; Figure 1d ). The proportion of dually positive uNK cells continued to be lower in the MLAp than DB in both strains, whereas the proportion of singly positive uNK cells did not differ significantly ( Table 1) . No differences were observed in gd12.5 B6 and Ncr1
Gfp/Gfp MLAp regarding either dually (P ¼ 0.649) or singly (P ¼ 0.693) positive uNK cells. Thus, the morphological alterations in Ncr1
Gfp/Gfp granule biogenesis are accompanied by a lower frequency of granule-contained cytolytic proteins by DBA þ uNK cells.
Angiokine expression is altered in Ncr1
Gfp/Gfp decidua and DBA þ uNK cells
In normal mice, VEGF is secreted from cytoplasmic vesicles of agranular (Type I) and granular (Types II-IV) DBA þ uNK cells.
9 PGF is also a major angiokine produced by uNK cells. To determine if the deficit in NCR1 signaling impacted production of molecules not stored in secretory-lysosomal granules, time course, quantitative immunohistochemical studies of VEGF and PGF reactivity in DBA þ uNK cells and total DB were undertaken. At gd6.5 when DBA þ uNK cells are rare, few VEGF-reactive cells were present in Ncr1
Gfp/Gfp and B6 implant sites. Analysis of VEGF fluorescence intensity within the whole decidua revealed elevated VEGF expression in Ncr1
Gfp/Gfp compared with B6 implant sites (Po0.0001) (Supplementary Figure S2) . Greater VEGF intensity was also observed in whole decidua of Ncr1
Gfp/Gfp mice compared with B6 at gd8.5 (Po0.001), 10.5 (Po0.001), and 12.5 (P ¼ 0.016) (data not shown). At gd8.5, when DBA þ uNK cell numbers have increased, VEGF expression within DBA þ uNK cells could be measured in addition to whole decidua. Higher VEGF levels were present in gd8.5 Ncr1
Gfp/Gfp DBA þ uNK cells than B6 (P ¼ 0.021). The difference in VEGF immunoreactivity of uNK cells was more pronounced at gd10.5 (P ¼ 0.011) but had equalized by gd12.5 (P ¼ 0.175) (Figure 4a-c) .
PGF expression within gd6.5 decidua did not differ between B6 and Ncr1
Gfp/Gfp implant sites (P ¼ 0.331) (Supplementary Figure S2) , however less total PGF expression was observed within Ncr1
Gfp/Gfp decidua than B6 at gd8.5 (P ¼ 0.01), 10.5 (P ¼ 0.029), and 12.5 (Po0.001) (data not shown). When gd8.5 DBA þ uNK cells were assessed for PGF expression, significantly less PGF reactivity was detected in Ncr1
Gfp/Gfp than B6 (P ¼ 0.002) This trend continued at gd10.5 (P ¼ 0.034). At gd12.5, in contrast to total decidua, PGF levels in DBA þ uNK cells normalized between genotypes (P ¼ 0.187) (Figure 4b) . Thus, Ncr1 gene inactivation inversely dysregulates VEGF and PGF expression in decidua and within uNK cells. Gfp/Gfp (d) uNK cell cytoplasm. At gd10.5 (e, f), B6 uNK cell granules (e) are mature. They remain round but are larger with a well-defined cortical membrane cap and a solid, electron dense core (outlined in ei and at higher power in eii). In gd10.5 Ncr1
Gfp/Gfp uNK cells (f), granules are structurally variable with many having anomalous electron light core regions (fi; arrowheads), and irregular shapes with atypical cortical caps (fii). Images are representative of ultrastructure studies conducted on two implantation sites from three different pregnancies per gd per genotype. gd, gestation day; GFP, green fluorescent protein; NCR1, natural cytotoxicity receptor; uNK, uterine natural killer.
uNK cells are detected in high numbers in B6 mice at gd6.5 and 8.5 by WM-IHC. 1 Proportionally, DBA þ uNK cells in Ncr1
Gfp/Gfp DB are similar in frequency to those in B6 at gd6.5 (P ¼ 0.261) and 8.5 (P ¼ 0.207) but the Ly49C/I þ subset is diminished (gd6.5: 17.3 ± 3.1% vs. 32.7 ± 3.1% in B6; P ¼ 0.004; gd8.5: 13.3±1.5% vs. 20.3±3.5% in B6; P ¼ 0.034) (Figure  5a, b) . The proportions of both uNK cell subsets change drastically in B6 DB between gd6.5 and 8.5, with LY49C/I þ (i.e., DBA-) uNK cells decreasing and DBA þ uNK cells increasing. In Ncr1
Gfp/Gfp DB, DBA þ uNK cell frequencies increased between gd6.5 and 8.5 (P ¼ 0.038), but Ly49C/I þ (DBA-) uNK cells were unchanged in frequency between these times (P ¼ 0.112) (Figure 5a, b) . Leukocytes other than NK cells are present in early decidua, therefore their frequencies were assessed. CD8 þ T cells, while not significantly different between genotypes at gd6.5 (P ¼ 0.886) trended to more frequent at gd8.5 in Ncr1
Gfp/Gfp than in B6 (11.7 ± 3.2% vs.
7.0 ± 1.7%; P ¼ 0.091). CD4 þ T cells were less frequent in Ncr1 Gfp/Gfp than B6 at gd6.5 (2.7 ± 0.6% vs. 5.3 ± 1.2%; P ¼ 0.023) and of similar frequency to B6 at gd8.5 (8.0 ± 1.7% vs. 7.0 ± 8.7%; P ¼ 0.749), showing a significant increase between gd6.5 and 8.5 (P ¼ 0.007). All other leukocyte populations were similar to B6 at gd6.5 and 8.5 (Figure 5a, b) .
To determine whether loss of NCR1 expression altered the frequency of CD45 þ leukocyte conjugate formation, WH-IHC was used to compare gd6.5 and gd8.5 Ncr1
Gfp/Gfp to B6 implant sites. Fewer CD45 þ /CD45 þ conjugates occurred in Ncr1
Gfp/Gfp than B6 DB at gd6.5 (5.2 ± 0.6% vs. 7.8 ± 1.0%; P ¼ 0.001) and gd8.5 (11.7 ± 1.4% vs. 19.0 ± 1.8%; Po0.001). As in B6 controls, a significant increase in the proportion of Ncr1
Gfp/Gfp CD45 þ cells forming conjugates occurred between gd6.5 and 8.5 (P ¼ 0.001) (Figure 5c ). Gfp/Gfp mice display both PRF and GZMA expression (yellow circle), whereas others express solely PRF (green circle). In addition, a consistent proportion of DBA þ uNK cells are unreactive for either lytic protein (white circle). At gd10.5 (c) in DB (i), many DBA þ uNK cells express both lytic proteins or PRF singly. While PRF/GZMA co-expression is less common in MLAp (ii). At gd12.5 (d) uNK cells expressing lytic proteins are present in Ncr1 Gfp/Gfp DB (i) and MLAp (ii) and occur in similar expression patterns. No DBA þ uNK cells expressing only GZMA are observed at any gd studied. Images are representative of three replicate experiments using two implantation sites from three different pregnancies. DBA, dolichos biflorus agglutinin; DB, decidua basalis; gd, gestation day; GFP, green fluorescent protein; GZMA, granzyme A; MLAp, mesometrial lymphoid aggregate of pregnancy; PRF, perforin; NCR1, natural cytotoxicity receptor; uNK, uterine natural killer.
CD45 þ /CD31 þ conjugated cells. Gains in expression of CD31, an adhesion molecule expressed by endothelial cells, platelets, and immune cell subsets, 31 were previously reported for gd6.5 B6 decidual CD45 þ cells with 90% co-expression by gd8.5.
1 Costaining of Ncr1
Gfp/Gfp implant sites with anti-CD45 APC and anti-CD31 PE revealed fewer CD45 þ leukocytes co-expressing CD31 than in B6 controls at gd6.5 (P ¼ 0.033) and gd8.5 (P ¼ 0.005) (Figure 5d ). The proportion of CD31 þ CD45 þ cells increased statistically in Ncr1
Gfp/Gfp but not B6 between gd6.5 and 8.5 (Figure 5d ; P ¼ 0.021). When Ncr1
Gfp/Gfp CD31 þ CD45 þ decidual cells were analysed by conjugation status, lower gd6.5 CD31 expression was attributed to less expression by nonconjugated CD45 þ cells (P ¼ 0.030 vs. B6). Conjugated gd6.5 CD31 þ CD45 þ cells were similar in frequency to B6 (22.3 ± 4.2% vs. 29.3 ± 5.8% (B6); P ¼ 0.164) (Supplementary Figure S3A) . By gd8.5, proportions of conjugated and unconjugated CD31 þ CD45 þ Ncr1
Gfp/Gfp cells were similar to B6 controls (P ¼ 0.361 and 0.334, respectively). In addition, the proportion of conjugated Ncr1
Gfp/Gfp CD31 þ cells in either
conjugates was similar to B6 (P ¼ 0.165) (Supplementary Figure S3B) .
DBA þ uNK cell conjugations. Despite the loss of Ncr1, DBA þ uNK cells formed conjugates at similar frequencies to those in B6 at gd6.5 and 8.5 (data not shown). Examination of leukocytes forming heterologous conjugates with DBA þ uNK cells indicated no differences in the composition of DBA þ heterologous conjugates at gd6.5 or 8.5 (Supplementary Figure S3C,  S3D) . With the exception of CD4 þ T cells, there was no change in Ncr1
Gfp/Gfp DBA þ leukocyte conjugate frequencies between gd6.5 and 8.5. CD4 þ T cells had no participation in heterologous conjugates with DBA þ uNK cells at gd6.5 but accounted for 11.6 ± 4.6% of these conjugates at gd8.5 (P ¼ 0.012 vs. gd8.5) (Supplementary Figure S3D) .
Conjugates not involving uNK cells. Leukocytes were involved in heterologous conjugation events independent of DBA þ uNK cells at both gd6.5 and 8.5. The only observed differences between Ncr1
Gfp/Gfp and B6 mice in non-uNK cell leukocyte heterologous conjugate formation occurred in CD11c þ dendritic cells (DCs) at gd6.5. At this time, Ncr1
Gfp/Gfp CD11c þ DCs formed heterologous conjugates not involving DBA þ uNK cells at a frequency of 17.3±2.3% vs. 24.5±3.0% in B6 (Supplementary Figure S3E ; P ¼ 0.019). Fewer non-uNK cell heterologous CD4 þ and CD8 þ T-cell conjugates were also observed in at gd6.5Ncr1
Gfp/Gfp , but these did not reach statistical significance (CD4 þ : P ¼ 0.067; CD8 þ : P ¼ 0.078 vs. B6). No differences were observed in types or frequency of 
(iii). (c) VEGF expression is significantly increased in Ncr1
Gfp/Gfp uNK cells compared with B6 at gd8.5 and 10.
(d-e) Representative images of PGF staining in B6 (d) and Ncr1
Gfp/Gfp (e) decidua at gd8.5 (i), 10.5 (ii), and 12.
(iii). (f) PGF expression in DBA þ uNK cells is significantly less in Ncr1
Gfp/Gfp compared with B6 at gd8.5 and 10.5. Images are representative of three replicate experiments using two implantation sites from three independent pregnancies per gd per genotype. Data were assessed by an unpaired Student's t-test. *Po0.05, **Po0.01, Data represent mean±s.d. DBA, dolichos biflorus agglutinin; gd, gestation day; GFP, green fluorescent protein; NCR1, natural cytotoxicity receptor; NS, not significant; PGF, placental growth factor; uNK, uterine natural killer; VEGF, vascular endothelial growth factor. non-uNK cell heterologous conjugate formation between strains at gd8.5 (Supplementary Figure S3E, S3F) .
DISCUSSION
This study builds from an initial report that documented biased expression of NCR1 by DBA þ uNK cells and reported essential roles for NCR1 in murine pregnancy. 20 In the initial study, normal numbers of uNK cells were described in Ncr1
Gfp/Gfp mice, but they were smaller than in gestation stage-matched control mice. Early Ncr1
Gfp/Gfp implant sites displayed limited angiogenesis and mildly delayed embryonic development, whereas midgestation sites lacked physiological spiral artery modification. 20 These features were accompanied by increased fetal resorption rates but did not limit overall pregnancy success in breeding pairs. To further understand the importance of NCR1 in uNK cell maturation, function and promotion of pregnancy success, in depth studies were undertaken. NCR1 (NKp46) is a highly conserved transmembrane receptor specific to NK cells and is expressed at all stages of mouse and human NK cell development. 32, 33 The gestationally unique, angiogenesis-promoting DBA þ uNK cell subset expresses eight-fold more Ncr1 RNA than the splenic-NK cell-like DBA-uNK cell subtype, 20 thus our study focused on the DBA þ uNK cell subset.
Morphological assessments of uNK cell maturity employ cell diameter, cytoplasmic granule number, and nuclear morphology. 4 Ncr1 Gfp/Gfp mice had higher proportions of immature uNK cell subtypes across early and midpregnancy than gd-matched controls. This was particularly apparent at gd12.5 when uNK cells in DB of control mice are fully mature, senescent cells thought to be stationary, cytokine secreting cells proceeding to apoptosis. 29, 34 In Ncr1
Gfp/Gfp , the most immature Type I agranular uNK cells persisted to gd12.5 and fully mature Type IV uNK cells were infrequent. These data support the conclusion derived from cell diameter measurements that NCR1 participates in the stepwise maturation of uNK cells. As Type IV uNK cells are observed in Ncr1
Gfp/Gfp DB, their diminished numbers are likely due to maturation delay and overall uNK cell immaturity than to an incapacity for terminal differentiation. Human pNK cells acquire NKp46 after CD56 and constitutive NKp46 expression occurs in NK cells in lymph node, lung, liver, and blood. 32, 35 UNK cells present in late menstrual cycle endometrium 36 and early decidua 28 also constitutively express the receptor. Thus, NKp46 may contribute to human uNK cell maturation. Gfp/Gfp mice at both gd compared with controls. **Po0.01, ***Po0.001. (d) The proportion of CD45 þ leukocytes with surface expression of the activation marker CD31 is significantly reduced by loss of Ncr1 at gd6.5 and 8.5. Co-expression of CD45 and CD31 is greater at gd8.5 than 6.5 in Ncr1
Gfp/Gfp mice, but no difference between gd in B6 mice. *Po0.05, **Po0.01 vs. B6; # Po0.05 vs. gd6.5. Images are representative of three replicate experiments using two implantation sites from three independent pregnancies per gd per genotype. Data represent mean ± s.d. For statistical analysis data were analyzed by one-way ANOVA with post hoc Tukey's multiple comparison test. The data shown here as two separate graphs (a and b) were grouped prior to analysis. ANOVA, analysis of variance; DBA, dolichos biflorus agglutinin; gd, gestation day; GFP, green fluorescent protein; NCR1, natural cytotoxicity receptor; uNK, uterine natural killer.
Ultrastructural studies identified biosynthetic roles for NCR1 within uNK cells. Although Ncr1
Gfp/Gfp uNK cells contained smaller but structurally typical granules at gd6.5 and 8.5, uNK cells at later gd contained atypical granules, 9, 29, 37 although granule number per cell did not differ from controls. Granule functionality was assessed by immunoreactivity quantification of two granule-associated proteins, PRF and GZMA. At gd6.5 and 8.5, when granules are still developing, Ncr1
Gfp/Gfp decidua contained fewer uNK cells coexpressing PRF and GZMA and induction of GZMA synthesis appeared to be delayed as uNK cells solely expressing PRF were at a much higher frequency than in controls. At gd10.5 when ultrastructural differences were apparent between Ncr1
Gfp/Gfp and B6 granules, GZMA expression by Ncr1
Gfp/Gfp uNK cells was also significantly lower ( Table 1) . Acquisition of lytic granules transitions NK cells from immature to mature, and occurs in uNK cells despite their limited lytic function. 9 Thus, these studies reinforce the conclusion drawn from the morphological subtyping that DBA þ Ncr1
Gfp/Gfp uNK cells are immature. In cytotoxic pNK cells, PRF enables GZMA-mediated apoptosis 38 and during pregnancy PRF induction in uNK cells occurs as a result of maternal stimulation independent of circulating pregnancy hormones. 39 Identity of the maternal factors responsible for PRF induction remains unknown but treatment of first trimester human uNK cells with decidual stromal cell-derived IL-33 significantly attenuated uNK cell cytotoxicity and decreased the expression of the activating receptors NKp30 and NKG2D (NKp46 expression was not measured). 40 Gains in NKp30 and NKp46 expression by human NK cell precursors increases NK cell cytolytic activity. 35 Together these data implicate local paracrine signals from maternal decidua and NCRs in acquisition of lytic proteins by NK cells, including lytically inert uNK cells.
DBA þ uNK cells are potent regulators of early decidual vascular development, 8, 13 producing angiokines, contributing to nascent blood vessel pruning, 41 and modifying existing maternal arteries, 14 VEGF and PGF, hallmark uNK cell products, were examined to address whether NCR1 signaling is required for angiokine synthesis. A reciprocal impact of elevated VEGF and reduced PGF was identified that may reflect changes in synthesis rather than altered consumption, however the latter cannot be ruled out as components of the VEGFR signaling family were not studied. Ncr1
Gfp/Gfp mice with significantly reduced PGF production have impairments in decidual angiogenesis 20 similar to mice lacking PGF, 42 suggesting that maternal VEGF is unable to substitute for PGF in normal implantation sites. This may be relevant to the pathophysiology of PGF-deficient human preeclampsia. 43 PanLy49 receptor-deficient mice also show impairments in uNK cell maturation and decidual vasculogenesis resembling Ncr1
Gfp/Gfp , however, VEGF expression is reduced in this strain. 16 Multiple reports suggest that PGF stimulates VEGF activity, 44, 45 but PGF can also antagonize VEGF activity when it is co-produced by single cells. 46 The differences in regulation of VEGF suggest a complexity that requires future study to better understand the regulatory pathways controlling angiokine production and secretion by uNK cells.
Prior to immune synapse formation between NK cells and target cells, NKp46 (NCR1) is uniformly distributed on human NK cell membranes. After target cell contact, NKp46 segregates rapidly into large clusters at the point of contact, which affects cytoskeletal rearrangement, influences F-actin assembly, and directs granule polarization. 33 Human uNK cells in contrast form immature synapses that fail to polarize granules to the synapse. 11 Interestingly, of the NCRs, only NKp46 is able to induce granule polarization in human uNK cells upon receptor ligation. 17 These studies suggested that uNK cell conjugate formation might be impaired in NCR1-deficient mice. Indeed, significantly fewer CD45 þ /CD45 þ conjugates were present at gd6.5 and 8.5 in Ncr1
Gfp/Gfp decidua, but the proportion and composition of DBA þ cell conjugates was not significantly altered from controls.
At gd6.5, the proportion of CD11c þ DCs forming heterologous conjugates that did not include DBA þ uNK cells fully accounted for the overall deficits in CD45 þ /CD45 þ conjugate formation. Although these conjugates likely included DBA-(Ly49C/I þ ) uNK cells, their numbers are unlikely to be affected as Ncr1 is expressed at low levels on DBA-uNK cells, 20 and no alterations were observed in Ncr1
Gfp/Gfp CD11c þ /DBA þ heterologous conjugates. Further, NKp30, rather than NKp46 or NKp44 is involved in human NK cells' lytic recognition of DCs 47 and regulatory synapses reported at the human maternalfetal interface, involve DC-SIGN on DCs and ICAM-3 on uNK cells. 48 Thus, none of the known DC-NK cell interactions predict NCR1 usage in mouse DC-NK conjugation and suggest that DC interactions with non-uNK cell lineages are reduced in Ncr1
Gfp/Gfp . This study highlights the importance of NCR1 for uNK cell maturation and function. Although many studies of uNK cells in human pregnancy complications focus on interactions between mismatched maternal killer immunoglobulin-like receptors and fetal HLA molecules, 15 our in vivo work along with that of others investigating NCRs on human uNK cells in culture highlights the significance of MHC-independent receptors in murine pregnancy and predicts that this receptor family has important roles in human pregnancy.
METHODS
Mice. Heterozygous Ncr1 loss of function breeding pairs on a C57BL/6 (B6) background (UkCa:B6.Ncr1 þ /Gfp (Ncr1 þ /Gfp) ) 23 were provided by Dr O. Mandelboim (Hebrew University-Hadassah Medical School, Jerusalem, Israel, through the laboratory of Dr F. Colucci (University of Cambridge, Cambridge UK)), bred to homozygosity (Ncr1 Gfp/Gfp ) at Queen's University and housed in a monitored, pathogen-free environment. Control B6 males and females were purchased at 7 weeks of age from Charles River Laboratories (St-Constant, QU, Canada). B6 or Ncr1
Gfp/Gfp studs were mated to B6 or Ncr1
Gfp/Gfp females, respectively. Matings were timed from copulation plug detection (gd0.5); euthanasia was by cervical dislocation at gd6.5, 8.5, 10.5, or 12.5. Mouse handling was in accordance with the guidelines of the Canadian Council on Animal Care and conducted under animal care protocols approved by Queen's University.
Immunostaining and morphometry. Implantation sites from gd6.5 to 12.5 Ncr1
Gfp/Gfp and B6 mice were dissected, immersion fixed in 4% paraformaldehyde, processed, and paraffin embedded. At least two healthy implantation sites from each pregnancy (n ¼ 3 pregnancies per genotype or 6 specimens per genotype) were cut as serial sections of 6mm and mounted onto glass slides. Each staining procedure (outlined below) was conducted as three replicate experiments. Stained slides were viewed with a Zeiss M1 imager (Zeiss, Toronto, ON, Canada) and photographed using Axiovision 4.8 software (Zeiss, Toronto, ON, Canada). Morphometric analyses were undertaken by a single blinded observer (AMF) using serial sections at least 42 mm apart to avoid duplicate enumeration of uNK cells.
(i) DBA lectin staining: Staining for DBA lectin-reactive uNK cells used published protocols. 4 DBA þ uNK cells were scored for maturation stage using previously published criteria involving diameter, cytoplasmic granule number, and nuclear morphology. 4 All nucleated uNK cells not residing in vascular spaces were enumerated and classified for maturity in at least five images captured at Â 400 magnification of DB (gd6.5-12.5) and/or MLAp (gd10.5-12.5) per specimen (n ¼ 6 specimens per gd per genotype).
(ii) Immunofluorescence for uNK cell products: Deparaffinized sections were pre-treated by heat-activated antigen retrieval (Tris-EDTA (10 mM) pH9.0 for VEGF, PRF, GZMA; Citrate buffer (10 mM) pH 6.0 for PGF) for 5-10 min. Sections were blocked with 1% PBS-BSA for 30 min at room temperature and subsequently incubated either overnight at 4 1C with 5 mg ml À 1 rabbit anti-mouse VEGFA (Abcam, Toronto, ON, Canada; ab46154) or 40 mg ml À 1 rat anti-mouse PRF (Abcam; ab16074) and 4 mg ml À 1 goat anti-mouse GZMA (Santa Cruz Biotech, Dallas, TX; sc5510), or for 2 h (room temperature) with 5 mg ml À 1 rabbit anti-PGF (Abcam; ab9542). Fluorescently conjugated secondary antibodies (10 mg ml À 1 goat anti-rabbit Alexa fluor 594 (ThermoFisher, Eugene, OR, USA; A-11012), 10 mg ml À 1 goat anti-rat Alexa Fluor 594 (Abcam; ab150160), or 7.5 mg ml À 1 donkey anti-goat Alexa Fluor 647 (Jackson ImmunoResearch, West Grove, PA; 705-605-147) and 10 mg ml À 1 DBA lectin FITC (Vector Laboratories, Burlingame, CA; FL-1031)) were then added (1 h, room temperature). The nuclei were visualized by DAPI staining with ProLong Gold antifade reagent with DAPI (ThermoFisher). For VEGF and PGF staining, the multidimensional acquisition feature in Axiovision 4.8 software was used to set manual exposure times for DAPI and DBA lectin, whereas VEGF/PGF was set to auto-exposure, thereby producing an unbiased image based on software-detected staining intensity. Ten images captured at Â 400 magnification (n ¼ 6 specimens per gd per genotype) were analyzed for pixel intensity using GNU Image Manipulation Program (GIMP 2.8.10 software, Gimp.org). For PRF and GZMA dual staining, at least seven images captured at Â 400 magnification were analyzed for expression in all uNK cells per field of view. DBA þ granules were also scored in each nucleated, granulated uNK cell (n ¼ 6 specimens per gd per genotype).
Ultrastructure. For electron microscopy, 1 mm 3 pieces of gd6.5, 8.5, and 10.5 Ncr1
Gfp/Gfp and B6 DB (n ¼ 3 litters per genotype with at least two implantation sites from each litter) were immersion fixed (2% paraformaldehyde, 2.5% glutaraldehyde, 24-48 h). Post-fixation tissues were washed in 70% ethanol and incubated (1 h room temperature) in 1% osmium tetroxide, then dehydration and embedding procedures were performed following manufacturer's recommendations (Embed 812 resin; Electron Microscopy Science-EMS). Semi-thin sections (1 mm) were stained with toluidine blue and ultra-thin sections were contrasted with uranyl acetate and lead citrate; micrographs were taken on a Hitachi H-7000 transmission electron microscope (Hitachi, Tokyo, Japan).
Whole-mount in situ immunohistochemistry. Gd6.5 and 8.5 implantation sites from at least three different Ncr1
Gfp/Gfp litters per gd were studied using WM-IHC as previously described. 2 Any small, abnormally pale, or resorbing implantation sites were excluded. Under microscopic magnification, separated implantation sites were incised antimesometrially and myometrium was retracted away. Each decidual capsule was then bisected midsagittally using a scalpel blade and incubated in 200 ml PBS-1% BSA-0.1% sodium azide (PBA) for 1 h with 10 mg ml À 1 of blocking antibody to the IgG Fc receptor (anti-CD16/CD32; supernatant of hybridoma 2.4G2, ATTC, Manassas, VA, USA) and 2-10 mg ml À 1 of up to three differently conjugated fluorescent primary antibodies (Supplementary Table S1 ). For DBA lectin staining, implantation sites were transferred to 200 ml fresh PBA, and incubated for an additional 10 min with 30 mg ml À 1 FITC-or 15 mg ml À 1 TRITC-conjugated DBA lectin (Supplementary Table S1 ). Supplementary Table S2 presents the antibody combinations used. Labeling was terminated by addition of 1 ml PBA. The intact, live tissue was placed on a microscope slide with the cut surface facing upward, coverslipped, viewed by epifluorescence microscopy, and photographed using an AxioCam-equipped Zeiss M1 imager with Axiovision 4.8 software. Different antibody staining combinations were used in studies of littermates.
Conjugate assessment. Leukocyte conjugates were analyzed using 10 epifluorescence images captured at Â 200 magnification. Leukocyteleukocyte pairs were scored as described in Felker and Croy.
1 Briefly conjugation was scored when two CD45 þ cells were observed in close contact in the same plane of focus with a slight flattening of both cells' membranes at the point of contact. At least 50 CD45 þ conjugates were counted for each antibody combination in two implantation sites from three different litters. Each cell of the pair was scored for antibody reactivity. Conjugates were scored as homologous when the two CD45 þ cells shared expression of surface marker under study or heterologous when the two CD45 þ cells expressed dissimilar surface markers.
Statistical analyses. Statistical significance for immunofluorescence analyses and conjugated cell counts was assessed by Student's t-test or one-way analysis of variance with post hoc Tukey's multiple comparison test using Prism5 Software (GraphPad Software, La Jolla, CA). Po0.05 was considered significant. Data are expressed as mean ± s.d.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
